Crispr Therapeutics shares owned by Capital Fund Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Capital Fund Management
from 13F filings
Historical chart of Capital Fund Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Capital Fund Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Capital Fund Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $563k | 12k | 45.39 |
| 2023-06-30 | $4.9M | 87k | 56.14 |
| 2023-03-31 | $9.5M | 210k | 45.23 |
| 2022-12-31 | $7.3M | 179k | 40.65 |
| 2022-09-30 | $5.9M | 90k | 65.35 |
| 2022-06-30 | $8.1M | 134k | 60.77 |
| 2022-03-31 | $21M | 341k | 62.77 |
| 2021-12-31 | $8.5M | 112k | 75.78 |
| 2021-09-30 | $16M | 139k | 111.93 |
| 2021-06-30 | $6.1M | 37k | 161.89 |
| 2021-03-31 | $16M | 131k | 121.85 |
| 2020-09-30 | $908k | 11k | 83.64 |
| 2020-06-30 | $1.2M | 17k | 73.49 |
| 2020-03-31 | $1.0M | 25k | 42.36 |
| 2019-12-31 | $211k | 3.5k | 60.81 |
| 2019-03-31 | $489k | 17k | 28.60 |
| 2018-12-31 | $489k | 17k | 28.60 |
| 2018-09-30 | $4.2M | 94k | 44.33 |